Markets:

Overview

News

Currencies

International

Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

43.84 +0.09 (+0.22%)

Streaming Delayed Price Updated: 1:07 PM EDT, Jul 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sanofi - American Depositary Shares

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

42 43 Next >

Why Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

October 27, 2023

Gainers NKGen Biotech, Inc. (NASDAQ: NKGN) shares surged 60.9% to $6.08 in pre-market trading after gaining 8% on Thursday. NKGen Biotech presented Phase I clinical trial data at the 16th Annual...

Via Benzinga

Sanofi Goes The Rival Way: Plans Separation Of Consumer Healthcare Unit ↗

October 27, 2023

Sanofi SA (NASDAQ: SNY) plans to spin off its consumer healthcare business as the French pharmaceutical company outlined its strategic update to increase investment in its drug-development pipeline and...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

October 27, 2023

It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday!

Via InvestorPlace

Looking Into Sanofi's Recent Short Interest ↗

October 26, 2023

Via Benzinga

Preview: Sanofi's Earnings ↗

October 26, 2023

Via Benzinga

(SNY) - Analyzing Sanofi's Short Interest ↗

October 09, 2023

Via Benzinga

What's Going On With Mirati Therapeutics Stock? ↗

October 06, 2023

Mirati Therapeutics, Inc. (NASDAQ: MRTX) shares are trading higher Friday.

Via Benzinga

Nasdaq, S&P 500 Eye Rebound While Bitcoin Edges Down: Amazon's Q3 Lifts Tech Stocks As Traders Eye Fed's Favorite Inflation Gauge ↗

October 27, 2023

As Amazon, Inc. (NASDAQ:AMZN) hawked good tidings, the negative sentiment in the equity market appears to have reversed. The recovery could be in part due to traders looking for bargains following a...

Via Benzinga

Topics Economy Stocks

Ford, Sanofi, Enphase Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

October 27, 2023

U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Acurx Pharmaceuticals Share Price And Volume Are Surging Ahead Of Phase 2b Trial Data Release ($ACXP)

October 27, 2023

Via AB Newswire

Topics Death

Earnings Scheduled For October 27, 2023 ↗

October 27, 2023

Companies Reporting Before The Bell • Sanofi (NASDAQ:SNY) is projected to report quarterly earnings at $2.26 per share on revenue of $12.56 billion.

Via Benzinga

Sanofi Stock Relative Strength Rating Jumps To 84: One To Watch ↗

October 24, 2023

Additionally, Sanofi stock has a decent 83 Composite Rating out of 99, and an 80 Earnings Per Share Rating.

Via Investor's Business Daily

Roche Spends $7.1 Billion On Roivant Drug, Following Merck, Sanofi Into The Raging Hot Immunology Space ↗

October 23, 2023

Roche is joining Merck and Sanofi in the TL1A drug space. These drugs could treat stomach diseases.

Via Investor's Business Daily

Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments

October 24, 2023

EQNX::TICKER_START (NASDAQ:TCBP),(NYSE:CVM),(NASDAQ:INVO),(NASDAQ:SNY),(NYSE:PFE) EQNX::TICKER_END

Via FinancialNewsMedia

Dupixent® (dupilumab) Phase 3 Results Show Sustained Efficacy for Up to One Year in Children 1 to 11 Years of Age with Eosinophilic Esophagitis (EoE)

October 22, 2023

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market? ↗

October 23, 2023

Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises.

Via Benzinga

Topics Stocks

Sanofi Bridging the Gap between the Homeless and Society via Futsal

October 17, 2023

From sanofi-aventis Korea

Via Business Wire

Pfizer, Sanofi's Respiratory Syncytial Virus Products Faces Insurance And Logistical Hurdles To Protect Infants ↗

October 16, 2023

As the respiratory virus season kicks off, healthcare providers are racing against time to offer Pfizer Inc's (NYSE: PFE) vaccine, Abrysvo, to pregnant patients and Sanofi SA's (NASDAQ:

Via Benzinga

2 Healthcare Stocks Near 52-Week Highs Still Worth Buying ↗

October 16, 2023

These two large-cap biopharma companies could have more room to run.

Via The Motley Fool

Week In Review: Two China Biopharmas Announce Billion Dollar Deals ↗

October 14, 2023

MediLink Therapeutics out-licensed global rights for its antibody-drug conjugate candidate to BioNTech in a $1.1 billion agreement. Meanwhile, BioMap formed a collaboration with Sanofi in a deal with...

Via Talk Markets

2 Surefire Stocks That Could Make You Richer ↗

October 11, 2023

It won't happen overnight, but with these stocks, a little patience is all you need.

Via The Motley Fool

Mirati Therapeutics Snags $5.8 Billion Takeover Deal, But Shares Fall On Lowball Bid ↗

October 09, 2023

Bristol Myers Squibb hopes to buy Mirati Therapeutics for up to $5.8 billion.

Via Investor's Business Daily

Amgen's Adcomm Meeting Paves Way To Launch Boost For Mirati Therapeutics' Lung Cancer Drug: Analysts ↗

October 06, 2023

According to a report on Thursday, French pharma company Sanofi SA (NASDAQ: SNY) is reportedly exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc (NASDAQ: MRTX).

Via Benzinga

Palantir And PwC Team Up To Accelerate Data-Driven Operations, OpenAI Rival Secures Billions In Big Tech Backing, Six US States Brace For Healthcare Strike: Today's Top Stories ↗

October 04, 2023

Benzinga

Via Benzinga

Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble. ↗

October 04, 2023

The deal leans into the emerging TL1A drug class, potentially rivaling Roivant and Merck.

Via Investor's Business Daily

Sanofi, Teva Pledge $1.5B To Target Inflammatory Bowel Disease That Impacts Almost 10M People ↗

October 04, 2023

Sanofi SA (NASDAQ: SNY) and Teva Pharmaceutical Industries Ltd (NYSE: TEVA) have collaborated to co-develop and

Via Benzinga

Tiziana Advances Phase 2 Site Selection For Its Lead Clinical Program In Non-Active Secondary Progressive Multiple Sclerosis (SPMS) And The Company Prepares For Six-Month Clinical Data Update ↗

October 04, 2023

Tiziana Life Sciences Ltd. (NASDAQ: TLSA) recently announced the Company has initiated site selection for its lead intranasal anti-CD3 monoclonal antibody drug c

Via Benzinga

Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment

October 04, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Why Shares of Kymera Therapeutics Jumped on Tuesday ↗

October 03, 2023

The company had a big bounce after hitting a 52-week low the day before.

Via The Motley Fool

'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories ↗

October 03, 2023

Benzinga

Via Benzinga

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

42 43 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.